Showing 61 - 70 of 215
Hospitalists-physicians who focus their practice on the care of hospitalized patients - are increasingly being used to care for patients hospitalized with general medical conditions in the U.S., often displacing primary care physicians from what had previously been their domain. While most...
Persistent link: https://www.econbiz.de/10014070292
We consider the partitioning of care types into wings from the perspective of a hospital administrator, who wishes to optimize the use of a fixed number of beds that provide services for heterogeneous care types. Patients of each care type request admission to the hospital stochastically, and if...
Persistent link: https://www.econbiz.de/10014039630
Competition and prospective payment have been widely used to control health care costs but may together provide incentives to selectively reduce expenditures on high-cost relative to low-cost users. We use patient discharge and hospital financial data from California to examine the effects of...
Persistent link: https://www.econbiz.de/10014111384
General medical care in the United States has historically been provided by physicians who care for their patients in both ambulatory and hospital settings. Care is now increasingly divided between physicians specializing in hospital care (hospitalists) and ambulatory-based care primary care...
Persistent link: https://www.econbiz.de/10013142933
Most medical cost-effectiveness analyses include future costs only for related illnesses but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical...
Persistent link: https://www.econbiz.de/10005720571
Comparative effectiveness research (CER) can provide valuable information for patients, providers and payers. These stakeholders differ in their incentives to invest in CER. To maximize benefits from public investments in CER, it is important to understand the value of CER from the perspectives...
Persistent link: https://www.econbiz.de/10008519886
Since the Food and Drug Administration (FDA) Amendments of 1962, the average time from a drug's first worldwide patent application to its approval by the FDA has risen from 3.5 to 13.5 years. FDA policies and manufacturers' incentives suggest that more important drugs may have reached the market...
Persistent link: https://www.econbiz.de/10005133398
Persistent link: https://www.econbiz.de/10005096117
Competition and prospective payment systems have been widely used to attempt to control health care costs. Although much of the increase in medical costs over the past half-century has been concentrated among a few high-cost users of health care, prospective payment systems may provide...
Persistent link: https://www.econbiz.de/10005579667
Competition and prospective payment systems have been widely used to attempt to control health care costs. Though much of the increase in medical costs over the past half-century has been concentrated among a few high-cost users of health care,prospective payment systems may provide incentives...
Persistent link: https://www.econbiz.de/10005580682